page contents

Biogen Inc (NASDAQ:BIIB) price target lowered to $250.00 by BMO Capital Markets

Biogen Inc (NASDAQ:BIIB) price target lowered to $ 250.00 by BMO Capital Markets

Mar 22, 2019 (Market Exclusive via COMTEX) —

Analyst Ratings For Biogen Inc (NASDAQ:BIIB)

Today, BMO Capital Markets lowered its price target on Biogen Inc (NASDAQ:BIIB) to $ 250.00 per share.

There are 21 Hold Ratings, 8 Buy Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Biogen Inc (NASDAQ:BIIB) is Hold with a consensus target pric…
Nasdaq Search Results

Leave a Reply

Your email address will not be published. Required fields are marked *


This site uses Akismet to reduce spam. Learn how your comment data is processed.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.